All Biotech Is Going Lower - Cramer's Lightning Round (2/5/16)

|
Includes: BBT, FHN, IONS, KEY, LPX, REGN, WY
by: SA Editor Mohit Manghnani

Summary

Regeneron Pharmaceuticals will come back eventually.

Weyerhaeuser is a better stock than Louisiana-Pacific.

Ionis Pharmaceuticals is a good company, but it doesn't matter in the current environment.

Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Friday, February 5.

Neutral Call

Regeneron Pharmaceuticals (NASDAQ:REGN): This is a high-multiple stock that people hate. Cramer thinks it will come back in favor eventually.

Bearish Calls

Louisiana-Pacific (NYSE:LPX): It's a fine company and is making a comeback. Weyerhaeuser is better since they have 5% dividend yield which is good protection.

BB&T Bank (NYSE:BBT): It's a good company, but there are others which are doing better - KeyCorp (NYSE:KEY) and FirstHorizon (NYSE:FHN).

Ionis Pharmaceuticals (NASDAQ:IONS): Biotech is going lower and one should be able to take the pain. It's a good company but it doesn't matter now.

(Editor's note: There were no Bullish Calls on Friday's show)

::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::

Jim Cramer's Action Alerts PLUS: Check out Cramer's multi-million dollar charitable trust portfolio and uncover the stocks he thinks could be HUGE winners. Start your FREE 14-day trial now!

Get Cramer's Picks by email - It's free and takes only a few seconds to sign up.